Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberous sclerosis.

John R W Yates1

  • 1Department of Medical Genetics, University of Cambridge, Cambridge, UK. jrwy1@cam.ac.uk

European Journal of Human Genetics : EJHG
|July 27, 2006
PubMed
Summary
This summary is machine-generated.

Tuberous sclerosis, an inherited disease, presents challenges for families. Gene identification and protein studies illuminate its pathogenesis and offer hope for new drug therapies for manifestations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein concentrations.

American journal of human genetics·2021
Same author

Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration.

Nature communications·2020
Same author

Long-term cognitive outcomes in tuberous sclerosis complex.

Developmental medicine and child neurology·2019
Same author

Secular changes in severity of intellectual disability in tuberous sclerosis complex: A reflection of improved identification and treatment of epileptic spasms?

Epilepsia open·2018
Same author

Association of C-Reactive Protein Genetic Polymorphisms With Late Age-Related Macular Degeneration.

JAMA ophthalmology·2017
Same author

Analysis of copy number variation at DMBT1 and age-related macular degeneration.

BMC medical genetics·2016
Same journal

Parental and public views on genomic newborn screening: a systematic review.

European journal of human genetics : EJHG·2026
Same journal

Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF network.

European journal of human genetics : EJHG·2026
Same journal

Characterisation of the SMN1/2 locus using a highly specific variant caller on whole-genome sequence data from 500,000 individuals.

European journal of human genetics : EJHG·2026
Same journal

When truncation is not loss of function: neo-tail architecture as a determinant of pathogenicity in NMD-escaping frameshift variants.

European journal of human genetics : EJHG·2026
Same journal

CMIP as a novel candidate gene for neurodevelopmental and neuropsychiatric disorders.

European journal of human genetics : EJHG·2026
Same journal

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026
See all related articles

Area of Science:

  • Genetics and Molecular Biology
  • Cellular Signaling Pathways
  • Inherited Disease Pathogenesis

Background:

  • Tuberous sclerosis is a significant inherited disorder impacting families and caregivers.
  • Understanding the genetic basis and molecular mechanisms is crucial for managing the disease.

Purpose of the Study:

  • To elucidate the pathogenesis of tuberous sclerosis through gene and protein product analysis.
  • To explore novel therapeutic strategies for the disease's manifestations.

Main Methods:

  • Identification of causative genes for tuberous sclerosis.
  • Analysis of the function of identified protein products.
  • Investigation of signaling pathways involved in protein synthesis and cell growth.

Related Experiment Videos

Main Results:

  • Genetic and proteomic studies have illuminated the disease's pathogenesis.
  • New insights into signaling pathways regulating protein synthesis and cell growth have been obtained.

Conclusions:

  • The study provides a foundation for understanding tuberous sclerosis at a molecular level.
  • There is a promising potential for developing targeted drug therapies for specific manifestations of tuberous sclerosis.